Skip to content
GenoLensGenoLens

KCNJ13

Chr 2q37.1

potassium inwardly rectifying channel subfamily J member 13

Aliases:
Kir7.1, Kir1.4, LCA16
MANE:
ENST00000233826.4

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Retinal disorders

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Glaucoma (developmental)

  • Ophthalmological ciliopathies

  • Primary ciliary disorders

  • Rare multisystem ciliopathy disorders

  • Skeletal dysplasia

  • Structural eye disease

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Thoracic dystrophies

Disease associations (Open Targets)

  • Leber congenital amaurosis 16

    0.72
  • Leber congenital amaurosis

    0.62
  • snowflake vitreoretinal degeneration

    0.56
  • eye disorder

    0.37
  • inherited retinal dystrophy

    0.37
  • retinitis pigmentosa

    0.27
  • coronary artery disorder

    0.26
  • major depressive disorder

    0.20
  • epistaxis

    0.18
  • Retinal dystrophy

    0.17

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Inward rectifier potassium channel 13

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. KCNJ13 has a very low single channel conductance, low sensitivity to block by external barium and cesium, and no dependence of its inward rectification properties on the internal blocking particle magnesium

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.